Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2.
Intraperitoneal injection of zymosan in mice induced rapid extravasation and accumulation of plasma protein in the peritoneal cavity. Neutrophils began to appear in the peritoneal cavity after a lag period of approximately 3 hours. The injected mice exhibited a pain response (writhing) during the first 30 minutes after injection, but writhing ceased before protein or cell accumulation had reached maximum levels. The injection of zymosan induced synthesis of PGE2 (measured by RIA) which reached maximum levels at 30 minutes, then declined slowly. Peptido-leukotriene levels (detected by bioassay, RIA and HPLC) increased rapidly after injection, reached a peak within an hour of injection and declined to undetectable levels within 4 hours. The early peptido-LT was predominantly LTC4, while later, LTE4 was the major component. LTD4 levels remained low throughout and no LTB4 was detected at any time. Indomethacin treatment elevated levels of peptido-LTs, reduced PGE2 levels and inhibited writhing. Phenidone reduced peptido-LT levels. In vitro studies demonstrated that zymosan stimulates LTC4 synthesis by peritoneal cells whereas LTE4, LTD4, LTB4 or monoHETES were not detectable (using HPLC methods). The source of enzymes responsible for the in vivo metabolism of LTC4 to LTD4 and LTE4 could not be identified.
D000818:Animals; D001091:Arachidonate Lipoxygenases; D002449:Cell Aggregation / Q000187:drug effects; D015232:Dinoprostone; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007249:Inflammation / Q000139:chemically induced / Q000378:metabolism*; D007274:Injections, Intraperitoneal; D007975:Leukotriene B4 / Q000096:biosynthesis; D017999:Leukotriene E4; D008084:Lipoxygenase / Q000032:analysis; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010146:Pain / Q000139:chemically induced / Q000378:metabolism*; D011458:Prostaglandins E / Q000096:biosynthesis*; D011506:Proteins / Q000378:metabolism; D013189:SRS-A / Q000031:analogs & derivatives / Q000096:biosynthesis*; D015054:Zymosan / Q000494:pharmacology*
D011458:Prostaglandins E; D011506:Proteins; D013189:SRS-A; D007975:Leukotriene B4; D017999:Leukotriene E4; D015054:Zymosan; D001091:Arachidonate Lipoxygenases; D008084:Lipoxygenase; D015232:Dinoprostone; D007213:Indomethacin